This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
AAFP Balances Critical Need for Effective Pain Management, Realities of Opioid Abuse
Academy Position Paper Opposes Mandated CME, Other Barriers for Prescribers
By News Staff
In an Aug. 1 position paper, "Pain Management and Opioid Abuse" (16-page PDF; About PDFs), the Academy states that mandated CME could limit patient access to legitimate pain management needs. "Family physicians and other primary care clinicians play a vital role in effective pain management, including the prescribing of opioid analgesics. The creation of additional prescribing barriers for primary care physicians would limit patient access when there is a legitimate need for pain relief," the Academy said in a related news release.
- The AAFP has issued a formal position paper on opioid abuse and pain management, opposing mandated CME and any other barriers to family physicians' ability to prescribe these drugs.
- The Academy outlined several other points in the paper, including its view that the primary goal of pain management is to improve and maintain function.
- Regarding a recently approved FDA risk evaluation and mitigation strategy for extended-release and long-acting opioids, the AAFP said it will continue to work with the FDA and others to "ensure policies are in place to allow effective and safe opioid prescribing by family physicians for patients in their pain management programs."
These statements reiterate two existing AAFP policies, one of which opposes any action limiting patient access to physician-prescribed pharmaceuticals, and the other of which "opposes legislation or executive action that would require mandatory education of family physicians as a condition for prescribing specific drugs, such as opioids."
In addition, the Academy:
- supports development of evidence-based physician education to ensure the safest and most effective use of long-acting and extended-release opioids and to reduce the problem of opioid abuse;
- urges all states to obtain physician input when considering pain management regulation and legislation, as well as implement prescription drug monitoring programs and the interstate exchange of registry information as called for under the National All Schedules Prescription Electronic Reporting (NASPER) Act of 2005; and
- strongly advocates increased national funding to support research into evidence-based strategies for optimal pain management and incorporation of those strategies into the patient-centered medical home model.
Annals of Family Medicine Focuses on Opioids, Pain Care
Articles and study reports in the issue sketch out the appropriate role of prescription painkillers, outline data that indicate depressed patients are more likely to misuse opioids, and discuss the role primary care physicians should play in setting prescribing standards, as well as whether these drugs are an appropriate therapy for primary care patients.
In the position paper, the Academy also cited the FDA's recently issued risk evaluation and mitigation strategy for extended-release and long-acting opioids, saying it will continue to work with the FDA and others on projects such as the FDA's Safe Use Initiative to "ensure policies are in place to allow effective and safe opioid prescribing by family physicians for patients in their pain management programs."